- H43 -

Every 90 minutes a New Zealander dies from heart disease. Cardiovascular disease affects most families in New Zealand. Our mission is to reduce the number of people dying and suffering from this disease. News Introducing the Glenys Fitzpatrick Scholarship Worlds biggest CHD registry reveals thousands more patients across Australia HRI welcomes Olympian Duncan Armstrong OAM as Ambassador Heart Research Institute HRI pioneers fight against cardiovascular disease Researchers gather for AVBS 2024 conference Cancer drug offers hope for cardiovascular patients Breakthrough from the Centre for PAD Projects Targeting mechanisms underlying exerciseinduced protection to prevent and treat cardiometabolic disease in males and females Photoresponsive thrombin inhibitors enable precise control of localised antithrombotic therapy This project investigates the transformation of a direct thrombin inhibitor into a photoresponsive therapy for stroke with the aim to precisely control local anticoagulation using twophoton excitation lasers.